Myrexis, Inc. (MYRX)

OTCMKTS · Delayed Price · Currency is USD
0.0066
0.00 (0.00%)
At close: May 29, 2025
-34.00%
Market Cap 227.56K
Revenue (ttm) n/a
Net Income (ttm) -11.62M
Shares Out 34.48M
EPS (ttm) -0.39
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 300
Average Volume 14,129
Open 0.0066
Previous Close n/a
Day's Range 0.0066 - 0.0066
52-Week Range 0.0066 - 0.0110
Beta 1.01
RSI 37.96
Earnings Date n/a

About Myrexis

Myrexis, Inc. focuses on identifying, evaluating, and making financial investments in life sciences assets. The company was formerly known as Myriad Pharmaceuticals, Inc. and changed its name to Myrexis, Inc. in July 2010. Myrexis, Inc. is headquartered in New York, New York. [Read more]

Industry Shell Companies
Sector Financials
CEO Jonathan Couchman
Employees 1
Stock Exchange OTCMKTS
Ticker Symbol MYRX
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.